IP Library Granted Patent US 12,270,978
Granted Patent B2
US 12,270,978 · App. 17/155,575 · Granted Apr 8, 2025

Devices, systems, and methods for otology

Inventors: Eugene de Juan (Brisbane, CA); Signe Erickson (Brisbane, CA); Charles Limb (Brisbane, CA); Vrad Levering (Brisbane, CA)
Assignee: Spiral Therapeutics Inc.
G02B21/0012A61B1/018A61B1/227A61B17/29A61B17/320068A61B17/3205A61B17/3423A61B17/3468A61B17/3478A61B18/04A61B18/1485A61B18/20A61F2/958A61F11/20A61F11/202A61M31/00A61M31/002A61M37/0015G02B21/0032G02B21/22A61B2017/00115A61B2017/00787A61B2017/00867A61B2017/32007A61B2018/00327A61B2217/005A61F2002/183A61F2250/0067A61M2037/0023A61M2037/0046A61M2205/04A61M2210/0662A61M2210/0668
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,270,978
App. No.
17/155,575
Granted
Apr 8, 2025
Kind
B2
Abstract

Systems and methods can be employed for facilitating access and procedures in the outer, middle, and inner ear in order to diagnose or treat ear disorders including, but not limited to hearing loss and excessive ear wax. In some examples, the systems and methods include instruments and techniques that facilitate trans-tympanic membrane or trans-fibrous ring access to the middle ear. The systems and methods can also be used to improve accessibility for various otological surgical procedures, such as, but not limited to, cholesteatoma removal, tympanic membrane repair and ossicular chain repair.

Claims (30)

1. A method of treating a middle ear or inner ear disorder of a patient, the method comprising:

implanting a port device in an annulus tympanicus, and

accessing the middle ear of the patient by advancing a distal end portion of an otologic instrument through or adjacent to the annulus tympanicus of the patient, wherein the advancing the distal end portion of the otologic instrument through or adjacent to the annulus tympanicus is performed by passing the distal end portion of the otologic instrument through a passage defined by the port device.

2. The method of claim 1 , wherein the passage is curved and causes the distal end portion of the otologic instrument to curve as the distal end portion of the otologic instrument is passed through the passage.

3. The method of claim 1 , wherein the otologic instrument is a first otologic instrument, and further comprising accessing the middle ear of the patient by advancing a distal end portion of a second otologic instrument through or adjacent to the annulus tympanicus of the patient.

4. The method of claim 3 , wherein the distal end portions of the first and second otologic instruments are in the middle ear concurrently.

5. The method of claim 4 , wherein the first otologic instrument is an endoscope and the second otologic instrument is a diathermy instrument or an ultrasonic instrument.

6. The method of claim 4 , wherein the first otologic instrument is an endoscope and the second otologic instrument is an aspirating tissue cutter instrument.

7. The method of claim 1 , further comprising:

flooding the middle ear with a liquid; and

while the middle ear is flooded with the liquid, treating the middle ear or inner ear disorder using the otologic instrument.

8. The method of claim 4 , further comprising:

while both the first and second otologic instruments are positioned through or adjacent to the annulus tympanicus, concurrently using the first otologic instrument to provide direct visualization within the middle ear and using an end effector of the second otologic instrument within the middle ear to grasp tissue, cut tissue, cauterize tissue, inject a therapeutic formulation, aspirate fluid, irrigate fluid, or a combination thereof.

9. A method of treating a middle ear or inner ear disorder of a patient, the method comprising:

making a puncture or incision in or adjacent to an annulus tympanicus;

accessing the middle ear of the patient by advancing a distal end portion of an otologic instrument through or adjacent to the annulus tympanicus of the patient, wherein the advancing the distal end portion of the otologic instrument through or adjacent to the annulus tympanicus is performed by passing the distal end portion of the otologic instrument through the puncture or incision, wherein the otologic instrument is a first otologic instrument; and

accessing the middle ear of the patient by advancing a distal end portion of a second otologic instrument through or adjacent to the annulus tympanicus of the patient, wherein the distal end portions of the first and second otologic instruments are in the middle ear concurrently,

wherein the first otologic instrument is an endoscope and the second otologic instrument is an injection instrument configured to deliver a therapeutic formulation within the middle ear.

10. The method of claim 9 , wherein the injection instrument is configured to deliver a therapeutic formulation to a round window niche within the middle ear and comprises: a handle defining a longitudinal handle axis; an actuation mechanism coupled to the handle; and an injection instrument shaft extending distally from the handle along a longitudinal shaft axis, wherein a non-zero angle is defined between the longitudinal shaft axis and the longitudinal handle axis.

11. The method of claim 10 , wherein a ratio of a length of the injection instrument shaft to a diameter of the distal end portion of the injection instrument shaft is 400:1 to 50:1.

12. The method of claim 11 , wherein the diameter of the distal end portion of the injection instrument shaft is 0.1 mm to 0.7 mm.

13. The method of claim 12 , wherein the length of the injection instrument shaft is 30 mm to 90 mm.

14. The method of claim 13 , wherein the non-zero angle defined between the longitudinal shaft axis and the longitudinal handle axis of the injection instrument is 10° to 70°.

15. The method of claim 9 , wherein the endoscope is configured to provide direct visualization of the injection instrument within the middle ear and comprises: a handle defining a longitudinal handle axis; an actuation mechanism coupled to the handle; and an injection instrument shaft extending distally from the handle along a longitudinal shaft axis, wherein a non-zero angle is defined between the longitudinal shaft axis and the longitudinal handle axis.

16. The method of claim 13 , wherein the non-zero angle defined between the longitudinal shaft axis and the longitudinal handle axis of the endoscope is 10° to 70°.

17. A method of treating a middle ear or inner ear disorder of a patient, the method comprising:

making a puncture or incision in or adjacent to an annulus tympanicus;

accessing the middle ear of the patient by advancing a distal end portion of an otologic instrument through or adjacent to the annulus tympanicus of the patient, wherein the advancing the distal end portion of the otologic instrument through or adjacent to the annulus tympanicus is performed by passing the distal end portion of the otologic instrument through the puncture or incision, wherein the otologic instrument is a first otologic instrument;

accessing the middle ear of the patient by advancing a distal end portion of a second otologic instrument through or adjacent to the annulus tympanicus of the patient, wherein the distal end portions of the first and second otologic instruments are in the middle ear concurrently; and

while both the first and second otologic instruments are positioned through or adjacent to the annulus tympanicus, concurrently using the first otologic instrument to provide direct visualization within the middle ear and using an end effector of the second otologic instrument within the middle ear to grasp tissue, cut tissue, cauterize tissue, inject a therapeutic formulation, aspirate fluid, irrigate fluid, or a combination thereof, wherein the first otologic instrument is an endoscope and the second otologic instrument is an injection instrument configured to deliver the therapeutic formulation to a round window niche within the middle ear.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2021
From: JUAN, EUGENE DE; ERICKSON, SIGNE; LIMB, CHARLES; LEVERING, VRAD
To: SPIRAL THERAPEUTICS INC.
Reel/Frame 055458/0331 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2021
From: JUAN, EUGENE DE; ERICKSON, SIGNE; LEVERING, VRAD
To: SPIRAL THERAPEUTICS INC.
Reel/Frame 055458/0419 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2021
From: JUAN, EUGENE DE; PERIS, HUGO; ERICKSON, SIGNE; LEVERING, VRAD; TALREJA, NIKHIL
To: SPIRAL THERAPEUTICS INC.
Reel/Frame 055458/0476 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2021
From: JUAN, EUGENE DE; ERICKSON, SIGNE; LIMB, CHARLES; PERIS, HUGO; TALREJA, NIKHIL; AYOOB, ANDREW; LEVERING, VRAD
To: SPIRAL THERAPEUTICS INC.
Reel/Frame 055458/0217 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2021
From: JUAN, EUGENE DE; ERICKSON, SIGNE; LIMB, CHARLES; PERIS, HUGO; TALREJA, NIKHIL; AYOOB, ANDREW; LEVERING, VRAD
To: SPIRAL THERAPEUTICS INC.
Reel/Frame 055458/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2021
From: JUAN, EUGENE DE; ERICKSON, SIGNE; LIMB, CHARLES; PERIS, HUGO; TALREJA, NIKHIL; AYOOB, ANDREW
To: SPIRAL THERAPEUTICS INC.
Reel/Frame 055458/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2021
From: JUAN, EUGENE DE; PERIS, HUGO; ERICKSON, SIGNE; LEVERING, VRAD
To: SPIRAL THERAPEUTICS INC.
Reel/Frame 055458/0608 →
Continuity (10)
Provisional Application 63082996 · Sep 24, 2020
Provisional Application 63081015 · Sep 21, 2020
Provisional Application 63080510 · Sep 18, 2020
Provisional Application 63078141 · Sep 14, 2020
Provisional Application 63077448 · Sep 11, 2020
Provisional Application 63051568 · Jul 14, 2020
Provisional Application 63040495 · Jun 17, 2020
Provisional Application 63024183 · May 13, 2020
Provisional Application 62965481 · Jan 24, 2020
Related Publication 20210228411A1 · Jul 29, 2021
References Cited (43)
US 5421818A · Arenberg · 1995 [cited by applicant]
US 6024726A · Hill · 2000 [cited by applicant]
US 6045528A · Arenberg et al. · 2000 [cited by applicant]
US 6120484A · Silverstein · 2000 [cited by applicant]
US 6277148B1 · Dormer · 2001 [cited by examiner]
US 6440102B1 · Arenberg et al. · 2002 [cited by applicant]
US 6648873B2 · Arenberg et al. · 2003 [cited by applicant]
US 7351246B2 · Epley · 2008 [cited by applicant]
US 7704259B2 · Kaplan et al. · 2010 [cited by applicant]
US 8197461B1 · Arenberg et al. · 2012 [cited by applicant]
US 9352084B2 · Decker et al. · 2016 [cited by applicant]
US 9616207B2 · Verhoeven et al. · 2017 [cited by applicant]
US 10130514B2 · Imran et al. · 2018 [cited by applicant]
US 10492670B1 · Bendory et al. · 2019 [cited by applicant]
US 20030220536A1 · Hissong · 2003 [cited by applicant]
US 20040133099A1 · Dyer et al. · 2004 [cited by applicant]
US 20040172005A1 · Arenberg et al. · 2004 [cited by applicant]
US 20040181185A1 · Lee · 2004 [cited by applicant]
US 20060184143A1 · Jolly · 2006 [cited by examiner]
US 20110224629A1 · Jolly et al. · 2011 [cited by applicant]
US 20120179187A1 · Loushin et al. · 2012 [cited by applicant]
US 20120203200A1 · Kenney et al. · 2012 [cited by applicant]
US 20130060131A1 · Oghalai et al. · 2013 [cited by applicant]
US 20130085476A1 · Imran · 2013 [cited by applicant]
US 20130245569A1 · Jolly et al. · 2013 [cited by applicant]
US 20160346511A1 · Cohen et al. · 2016 [cited by applicant]
US 20170172804A1 · Watanabe et al. · 2017 [cited by applicant]
US 20170354431A1 · Rubin et al. · 2017 [cited by applicant]
US 20180303314A1 · Noyes · 2018 [cited by applicant]
US 20190015254A1 · Bendory et al. · 2019 [cited by applicant]
US 20190321610A1 · Goldfarb et al. · 2019 [cited by applicant]
US 20190350607A1 · Martone et al. · 2019 [cited by applicant]
US 20200094030A1 · Kim et al. · 2020 [cited by applicant]
JP 2002536114 · 2002 [cited by applicant]
JP 2019522539 · 2019 [cited by applicant]
WO WO2008097317 · 2008 [cited by applicant]
WO WO2019152866 · 2019 [cited by applicant]
WO WO2019200259 · 2019 [cited by applicant]
WO WO2020115674 · 2020 [cited by applicant]
Extended European Search Report in European Appln No. 21745163.2, dated Jan. 26, 2024, 6 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/US2021/014601, mailed on Aug. 4, 2022, 9 pages. [cited by applicant]
PCT Invitation to Pay Additional Fees and, where Applicable, Protest Fee in International Appln. No. PCT/US2021/14601, dated Mar. 30, 2021, 2 pages. [cited by applicant]
PCT International Search Report and Written Opinion in International Appln. No. PCT/US2021/014601, dated Jun. 3, 2021, 12 pages. [cited by applicant]
Cited By (1)
US 12,728,245